IDH1 and central nervous system cancer: Mutations in TP53 are important for the diagnostics of several glioma subtypes: IDH-mutant astrocytoma, H3 K27-altered diffuse midline glioma, H3 G34-mutant diffuse hemispheric glioma and SHH-activated medulloblastoma [3].